Published on 3 Aug 2022 on American City Business Journals
Senseonics poised to get diabetes device to more patients after big insurer expands coverage
The business predominantly generates revenue from sales to Ascensia through the partners’ agreement....
NYSE.SENS price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free